Previous studies have utilized small interfering RNA (siRNA) to knock down PAX2, demonstrating that PAX2 knockdown sensitized RCC cells to cisplatin-induced apoptosis, resulting in the death of 50–60% of cisplatin-resistant ACHN and CAKI-1 cells [22]. The gene discussed is PAX2; the disease is renal cell carcinoma.